-
1 Comment
Zhuhai Hokai Medical Instruments Co., Ltd is currently in a long term uptrend where the price is trading 0.7% above its 200 day moving average.
From a valuation standpoint, the stock is 56.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.2.
Zhuhai Hokai Medical Instruments Co., Ltd's total revenue sank by 50.0% to $194M since the same quarter in the previous year.
Its net income has increased by 191.1% to $35M since the same quarter in the previous year.
Finally, its free cash flow grew by 104.3% to $9M since the same quarter in the previous year.
Based on the above factors, Zhuhai Hokai Medical Instruments Co., Ltd gets an overall score of 4/5.
| Industry | Medical Devices |
|---|---|
| Sector | Healthcare |
| CurrencyCode | CNY |
| Exchange | SHE |
| ISIN | CNE1000018K1 |
| Beta | 0.78 |
|---|---|
| Target Price | 25.22 |
| PE Ratio | None |
| Market Cap | 2B |
| Dividend Yield | 0.0% |
Zhuhai Hokai Medical Instruments Co.,Ltd. produces and sells medical equipment in China. The company offers minimally invasive tumor, medical imaging and rehabilitation, and conventional equipment; medical gas engineering products; and hospital informatization products. It also provides oncology and intervention discipline, medical engineering and information, artificial intelligence system, and medical financial solutions, as well as rehabilitation discipline and hospital construction services; and financial leasing services. Zhuhai Hokai Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Zhuhai, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300273.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
